Abstract
Current thinking supports the belief that underlying the onset of the atherosclerotic lesion is chronic injury to the arterial endothelium. The action of shear stress as a consequence of patterns of blood flow, whether turbulent or laminar, and as engendered by branch points and flow dividers, may be the origin of the injury. A number of factors such as hypercholesterolemia, cigarette smoking, hypertension and immune complexes may act synergistically with chronic endothelial injury to increase the degree and rate of plaque formation. That the response to these risk factors, such as flow disturbances, may be influenced by variations of susceptibility of endothelial cells is suggested by the great variability of the age at onset, rate of progression among individuals, and extent of plaque size in different anatomical beds. The predisposition to the development of symptomatic atherosclerotic lesions of the extracranial carotid artery, the coronary circulation, particularly at branch points, the infrarenal aorta, the iliofemoral tract of the lower extremities, and the renal arteries, particularly their ostia, is well known. By contrast, the vessels of the upper extremity, the mid descending thoracic aorta, most of the visceral vessels, with the occasional exception of the orifices of the celiac axis and the superior mesenteric artery are rarely the site of atherosclerotic disease and even more rarely productive of symptoms. This variation in vulnerability from arterial bed to arterial bed supports the concept of heterogeneity of endothelial response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antiplatelet Trialists; Collaboration, 1988, Secondary prevention of vascular disease by prolonged anti-platelet treatment. BMJ 296:320–31.
Badimon, JJ.,Badimon, L., Fuster, V., 1990, Regression of atherosclerotic lesions by high density li-poprotein plasma fraction in the cholesterol-fed rabbit. J. Clin. Invest. 85:1234–41.
Bini, A., Fenoglia, J.J. Jr., Mesa-Tejada, R., Kudryk, B., Kaplan, KL., 1989, Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis: use of monoclonal antibody. Arteriosclerosis 9:109–121.
Blankenhorn, D.H., Johnson, R.L., Mack, W.J., el Zein, H.A., Vailas, L.I., 1990, The influence of diet on the appearance of new lesions in human coronary arteries. JAMA 263:1646–52.
Blankenhorn, D.H., Nessim, S.A. Johnson, R.L., Sanmarco, M.E., Azen, S.P. Cashen-Hemphill, L., 1988, Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 259:2698.
Brown, G., Albers, J.J., Fisher, L.D., et al., 1990, Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med 323:1289–98.
Bruschke, A.V.G., Kramer, J.R. Jr., Bal, T.E., Hague, I.U., Detrano, R.C., Goormastic, M., 1989, The dynamics of progressive coronary atherosclerosis studied in 168 medically treated patients who underwent coronary angiography three times. Am. Heart J. 117:296–305.
Buchwald, H., Varco, R.L., Matts, J.P., et al., 1990, Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N. Engl. J. Med 323:946–55.
Chester, A.H., O’Neill, G.S., Moncada, S., Tadjkarimi, S., Yacoub, M.H., 1990, Low basal and stimula-ted release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 336:897–900.
Cohen RA, Zitnay, K.M., Haudenschild, C.C., Cunningham, L.D., 1988, Loss of selective endothelial cell vasoactive stimuli in hypercholesterolemia in pig coronary arteries. Circ. Res. 63:903–10.
el-Tamini, H., Davies, G.J., Hackett, D., et al., 1991, Abnormal vasomotor changes early after coron-ary angioplasty. Circulation 84:1198–202.
Endothelins, 1991, Lancet 337:79–81.
Faggiotto, A., Ross, R., Harker, L., 1984, Studies of hypercholesterolemia in the non-human primate. Changes that lead to fatty streak formation. Arteriosclerosis 4:323–330.
Falk, E., 1985, Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 71:699–708.
Fischell, TA., Derby, G., Tse, T.M., Stadius, M.L., 1988, Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. Circulation 78:1323–4.
Frick, M.H., Elo, O., Haapa, K., et al., 1987, Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med 317:1237–45.
Furchgott, R.F., Zawadzki, J.V., 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 299:373–6.
Fuster, V., Stein, B., Ambrose, JA., Badimon, L., Badimon, H., Chesebro, J.H., 1990, Atherosclerotic plaque rupture and thrombosis: evolving concepts. Circulation 82 Suppl II:II-47-II-59.
Glagov, S., Zarins, C., Giddens, D.O., Ku, D.N., 1988, Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch. Pathol. Lab. Med. 112:1018–1031.
Gown, A.M., Tsukada, T., Ross, R., 1986, Human atherosclerosis II Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Path. 125:191–207.
Hackett, D., Davies, G., Choierchia, S., Maseri, A., 1987, Intermittent coronary occlusion in acute myocardial infarction: value of combined thrombolytic and vasodilatory therapy. N. Engl. J. Med. 2317:1055–9.
Hennekens, C.H., Buring, J.E., Sandecock, P., Collins, R., Peto, R., 1989, Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 80:749–56.
Kane, J.P., Malloy, M.K.J., Ports, TA., Phillips, N R, Diehl, J.C., Havel, R.J., 1990, Regression of cor-onary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 264:3007–12.
Maseri, A., L’Abbate, A., Baroldi, G., 1978, Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of “preinfarction” angina. N. Engl. J. Med. 299:1271.
McDowell, F.H., Caplan, L.R. (eds.). Cerebrovascular Survey Report, 1985, Bethesda, MD for the National Institute of Neurological and Communicative Disorders and Stroke, NIH, US Public Health Service.
Moncada, S., Gryglewski, R., Bunting, S., Vane, J.R., 1976, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–5.
Ornish, D., Brown, S.E., Scherwitz, L.W., et al., 1990, Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 336:129–33.
Palmer, R.MJ., Ashton, D.S., Moncada, S., 1988, Vascular endothelial cells synthesize nitric oxide from L arginine. Nature 333:664–6.
Reichl, D., Miller, N.E., 1989, Pathophysiology of reverse cholesterol transport: insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 9:785–97.
Richardson, P.D., Davies, M.J., Born, G.V.R., 1989, Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 2:941–4.
Ross, R., 1986, The pathogenesis of atherosclerosis - an update. N. Engl. J. Med. 314:488–500.
Rubin, E.M., Krauss, R.M., Spangler, EA., Verstuyft, J.G., Clift, S.M., 1991, Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 353:265–7.
Schwartz, CJ., Valente, AJ., Sprague, EA., Kelley, J.L., Nerem, R.M., 1991, The pathogenesis of ather-osclerosis. Clin. Cardiol. 14 Suppl I:I-1-I-16.
Smith, P., 1992, Antithrombotic therapy in the chronic phase of myocardial infarction. In: Fuster, V., Verstraete, M., eds. Thrombosis in Cardiovascular Disorders Philadelphia: E.B. Saunders, 529–44.
Smith, E.B., Kean, A., Grant, A., Stirk, C., 1990, Fate of fibrinogen in human arterial intima. Arteriosc-lerosis 10:263–275.
Steinberg, D., 1991, Antioxidants and atherosclerosis. Circulation 84:1420–5.
Steinberg, D., Partharsayrathy, S., Carew, T.E., Kohoo, J.C., and Witztum, J.L., 1989, Beyond cholesterol:modification of low density lipoprotein that increases its atherogenecity. N. Engl. J. Med. 320:915–924.
Steinbrecher, U.P., Partharsayrathy, S., Leake, D.S., Witztum, J.L., and Steinberg, D., 1984, Modifica-tion of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci., USA 83:3883–3887.
Thyberg, J., Hedin, U., Sjolund, M., Palmberg, L., Bottger, BA., 1990, Regulation of differentiated pr-operties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10:966–90.
Vane, J.R., Anggaard, E.E., Botting, R.M., 1990, Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323:27036.
Vanhoutte, P.M., Shimokawa, H., 1989, Endothelium-derived relaxing factor and coronary vasospasm. Circulation 80:1–9.
Wilcox, J.N., Smith, K.M., Williams, L.T., Schwartz, S.M., Gordon, D., 1988, Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J. Clin. Invest. 82:1134–43.
Yanagisawa, M., Kurihara, H., Kimura, S., et al., 1988, A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–5.
Yeung, A.C., Vekshtein, V.I., Krantz, D.S., et al., 1991, The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N. Engl. J. Med. 325:1551–1556.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Callow, A.D. (1993). The Clinical Profile of Atherosclerosis. In: Catravas, J.D., Callow, A.D., Ryan, U.S. (eds) Vascular Endothelium. NATO ASI Series, vol 257. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2437-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2437-3_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6035-3
Online ISBN: 978-1-4615-2437-3
eBook Packages: Springer Book Archive